Parenteral nutrition is a form of nutritional support that delivers nutrients, such as protein, fat, and carbohydrate, to the body through a tube directly into the stomach or small intestine. The global parenteral nutrition market is projected to reach USD 7.1 billion by 2028 from USD 5.6 billion in 2018 at a CAGR of 4.8%. The increasing prevalence of chronic diseases coupled with the rise in the adoption rate of minimally invasive surgical procedures is expected to drive growth over the forecast period.
Parenteral nutrition is a form of nutritional support. Nutrients are administered intravenously, bypassing the digestive tract. Parenteral nutrition provides complete and balanced nutrients for patients who have failed to maintain their weight or whose gastrointestinal absorptive capacity has been reduced due to intestinal disease or short bowel syndrome.
The major types of nutrients given are carbohydrates, parenteral lipid emulsion, single-dose amino acid solutions, trace elements, and vitamins and minerals. Parenteral nutrition provides these in a balanced ratio to meet the increased requirements for specific essential nutrients while minimizing metabolic imbalances that can occur when too many calories or protein are ingested orally.
On the basis of type, the global parenteral nutrition market is segmented into Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, and Vitamins & Minerals.
Carbohydrates provide energy through their breakdown into glucose by the liver without stimulation from insulin from other sources such as food. The primary source of carbohydrate is dextrose which has been associated with an increase in mortality rates due to hyperglycemia (increased blood sugar levels).
Carbohydrates play an important role in energy metabolism by being oxidized into molecules that can produce ATP (adenosine triphosphate). The use of carbohydrate-containing fluids has been reported in patients receiving radiation treatment because it provides high levels of glucose without nutrient overload from fat calories which would cause hyperlipidemia.
These contain various proportions of triglycerides, phospholipids, and cholesterol in an aqueous solution. These are used to treat hypoproteinemia (low levels of protein in the blood) or if intravenous therapy is not tolerated by the individual due to hypersensitivity reaction.
PLEs contain a mixture of lipids including long-chain triglycerides, medium-chain triglycerides, and free fatty acids with each type having different effects on cholesterol levels in the blood when given intravenously. These may also include phospholipids which provide protection against infections since they form protective barriers at sites where bacteria often enter into tissues.
Parenteral lipid emulsions are used in the treatment of patients with malabsorption syndromes, pancreatitis, and other conditions with fat malabsorption.
Single-dose amino acid solutions contain a single source of protein such as soy or whey isomaltase hydrolysates to provide essential arginine for growth hormone secretion which may be deficient from prolonged starvation. Trace elements have been reported to prevent anorexia by creating a sense of fullness and preventing wasting by maintaining muscle mass. Vitamins and minerals are used to correct deficiencies caused by malnutrition resulting from inadequate dietary intake due to disease-induced changes in taste perception, appetite suppression, or swallowing difficulties.
This provides essential amino acids which cannot be synthesized by humans such as arginine, glutamine, and glycine. Single-dose solutions can also provide nutritional support for acute hepatic failure where oral intake is not possible because there may be a risk of infection from absorption through the damaged intestinal lining.
Trace elements include iron, copper-zinc, and iodine which are required minerals that cannot be obtained from food sources. Trace elements are essential for the production of red blood cells, maintenance of the immune system, and healthy bones.
Vitamins are essential organic substances that cannot be synthesized by the human body and must be consumed through diet. The deficiency of vitamins can lead to dehydration, fatigue, anemia, and other complications such as heart problems or mental retardation in children. Vitamins such as A (as retinol palmitate), D and K may be administered in PN solutions to meet requirements when dietary intake is inadequate or unavailable. Vitamin C may also be added if there is a lack of adequate food sources available to provide this vitamin.
Minerals are inorganic substances that cannot be synthesized by the human body and must also be consumed through diet. Deficiency of minerals can lead to anemia, fatigue, weakness, or mental retardation among other complications such as heart problems or bone diseases. Minerals may enter PN solutions either in organic form (e.g., calcium) or in trace amounts for nutritional purposes only without causing any adverse effects on patient outcomes (e.g., copper).
On the basis of application, the global parenteral nutrition market is segmented into Premature Infants, Neonates, And Children(N&C), Geriatrics, Chronic Disease Patients (D).
Premature infants are typically born more than three weeks before their due date. They require special health care services to keep them healthy and strong, including medical treatment in the hospital setting which includes intravenous feedings or parenteral nutrition (PN). It is an important source of calories for premature babies who cannot yet handle solid foods by mouth because this type of food provides nutrients that support growth and development. PN can also be used as a "bridge" method when transitioning newborns from milk-only feeding to a combination with other solids.
For premature infants, parenteral nutrition is most often administered through a central venous catheter. Central veins are typically more accessible than peripheral and smaller in diameter so they can provide better intravenous flow rates. The term ‘parenteral’ means by or through the skin but this technique bypasses first passing through the intestinal tract. On the other hand, parenteral nutrition for neonates and children is given via peripheral vein (e.g., intravenous or subcutaneous) because it passes through the intestine first before reaching the bloodstream.
The application of parenteral nutrition for Neonates, And Children(N&C) is to provide them with the essential nutrients needed in order to grow. This type of nutritional support can be given through either an intravenous or a tube feeding method and it contains all essentials for growth like carbohydrates, protein, vitamins minerals, and more.
Neonates are one of the most susceptible categories to develop a metabolic disorder. Inadequate nutrition at this stage can lead to impaired growth and development, which in turn might affect their cognitive skills as well as bone integrity. Moreover, neonatal parenteral nutrition also helps premature babies who have difficulties digesting food because they do not have the necessary enzymes.
Geriatric patients may need parenteral nutrition when they cannot get enough nutrients through diet. Parenteral nutrition provides fluids, electrolytes, and glucose in high concentrations that are not tolerated by the human body. It is sometimes necessary for these types of patients because if their intestines don't work properly they won't be able to digest food into usable nutrients or absorb them sufficiently from the small intestine.
The use of parenteral nutrition has been proven effective for chronic disease patients because it can help stimulate gut motility via its action on gastrointestinal hormones; this helps facilitate digestion. In addition, enteral feedings have known risks associated with them; parenteral nutrition can be used for patients with an intolerance to enteral feedings.
On the basis of region, the global parenteral nutrition market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is the largest market for parenteral nutrition owing to the high prevalence of chronic diseases among the geriatric population in this region. The U.S., China, and Japan account for a significant growth rate in the North American parenteral nutrition market owing to a higher number of premature infants, neonatal and pediatric patients with nutritional deficiency cases. According to the World Health Organization (WHO), India has witnessed an increase in malnutrition rates due to a declining economy and lack of awareness about good diet practices leading to poor patient compliance towards oral intake as a result. Growth prospects are limited on account of stringent regulations such as Global Food Safety Initiative (GFSI) certification, which restricts imports from countries that do not comply with these standards.
The growth of the market can be attributed in part due to factors such as favorable reimbursement scenario for hospitals and manufacturers providing these products, increasing incidence rate of chronic diseases among adults with infections like HIV/AIDS or cancer, rising geriatric population base resulting from an overall increase in life expectancy, rise in a number of premature infants who are on ventilators requiring intravenous feeding and continuous need for infusion solutions that enhance nutritional status.
Up Market Research published a new report titled “Parenteral Nutrition Market research report which is segmented by Types (Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, Vitamins and Minerals), By Applications (Premature Infants, Neonates and Children, Geriatrics, Chronic Disease Patients), By Players/Companies Baxter International, Hospira, B. Braun Melsungen, Grifols International, Fresenius Kabi, Otsuka Pharmaceutical Factory, Actavis, Sichuan Kelun Pharmaceutical”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
|Report Attributes||Report Details|
|Report Title||Parenteral Nutrition Market Research Report|
|By Type||Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, Vitamins and Minerals|
|By Application||Premature Infants, Neonates and Children, Geriatrics, Chronic Disease Patients|
|By Companies||Baxter International, Hospira, B. Braun Melsungen, Grifols International, Fresenius Kabi, Otsuka Pharmaceutical Factory, Actavis, Sichuan Kelun Pharmaceutical|
|Regions Covered||North America, Europe, APAC, Latin America, MEA|
|Historical Year||2018 to 2019 (Data from 2010 can be provided as per availability)|
|Number of Pages||211|
|Number of Tables & Figures||148|
|Customization Available||Yes, the report can be customized as per your need.|
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Type Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, Vitamins and Minerals and By Application Premature Infants, Neonates and Children, Geriatrics, Chronic Disease Patients.
Some of the companies that are profiled in this report are:
Parenteral Nutrition Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Parenteral Nutrition Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Parenteral Nutrition Market Report:
Some other reports from this category!